New treatment approach shall soon be ready for use in Usher syndrome patients / Publication in “Human Gene Therapy”. Usher syndrome is the most common form of combined congenital deaf-blindness in humans and affects 1 in 6,000 of the population. It is …
Author: Medical News Today
New Drug Delivery Device Invented To Treat Diabetes-Related Vision Loss
A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes. Diabetic retinopathy is the l…
Eye Implant OZURDEX(R) Receives European Medicines Agency Authorisation For Non-Infectious Uveitis
Allergan announced today that the European Medicines Agency (EMA) has extended the Marketing Authorisation for OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) in the 27 member states of the European Union to include the treatment of …
Leave Fireworks To The Professionals This Fourth Of July: American Academy Of Ophthalmology Offers Tips For Fireworks Safety
Each Fourth of July, thousands of people are injured from using consumer fireworks. According to the U.S. Consumer Product Safety Commission, more than 9,000 fireworks-related injuries happen each year. Of these, nearly half are head-related injuries w…
Neuroscientists Find Famous Optical Illusion Surprisingly Potent
Scientists have come up with new insight into the brain processes that cause the following optical illusion: The yellow jacket (Rocky, the mascot of the University of Rochester) appears to be expanding. But he is not. He is staying still. We simply…
Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data From Phase II Clinical Trial Of MIM-D3 For Dry Eye Disease
Mimetogen Pharmaceuticals Inc. (“Mimetogen”) today announced positive top line data from a Phase II clinical trial with MIM-D3, its lead drug for the treatment of dry eye. The trial demonstrated statistically significant improvements in signs and sympt…
Physicist’s Discovery Alters Conventional Understanding Of Sight
A discovery by a team of researchers led by a Syracuse University physicist sheds new light on how the vision process is initiated. For almost 50 years, scientists have believed that light signals could not be initiated unless special light-receptor mo…
Cause Of Hereditary Blindness Discovered
Medics at the RUB have found the cause of hereditary, progressive blindness: they have identified the previously unknown protein CCDC66, the loss of which initially leads to night blindness and in due course usually results in complete blindness. The r…
Neurobiologists Have Determined The Number Of Circuits Needed To See Movements
Surely, everybody knows this phenomenon: an animal doesn’t stand out against its background and becomes visible to us only when it moves. The reason behind this is that we depend strongly on our eyesight for navigation, and the perception of motion is …
Discovery Of The Cause Of Hereditary Blindness
RUB Medicine: new protein identified Initially the occurrence of progressive retinal degeneration – progressive retinal atrophy, in man called retinitis pigmentosa – had been identified in Schapendoes dogs. Retinitis pigmentosa is the most common her…
Sight Requires Exact Pattern Of Neural Activity To Be Wired In The Womb
The precise wiring of our visual system depends upon the pattern of spontaneous activity within the brain that occurs well before birth, a new study by Yale researchers shows. “It isn’t just the genes…
Study Demonstrates Potential Of New Gene Vector To Broaden Treatment Of Eye Diseases
Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blinding disorders…
EyeMed Vision Care Adds Retinal Imaging Benefit In Support Of Eye Health And Vision Wellness
EyeMed Vision Care, one of the nation’s leading vision benefits companies and part of Luxottica (NYSE: LUX), a leader in vision care and eyewear, has begun offering retinal imaging as an optional benefit within a vision plan. Retinal imaging provides d…
Human Retina Protein Has The Molecular Capability To Function As A Light-Sensitive Magnetic Sensor
For migratory birds and sea turtles, the ability to sense the Earth’s magnetic field is crucial to navigating the long-distance voyages these animals undertake during migration. Humans, however, are widely assumed not to have an innate magnetic sense…
Poor Vision Leads To Falls For 270,000 Over-60s, UK
270,000 people in the UK aged 60+ who have fallen over in the last two years say that poor vision was a factor in their fall[i], according to new research released today to mark Age UK’s Falls Awareness Week 2011 (20-24 June). Many things can lead to …
Oxford BioMedica Announces Ocular Programme Update
Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment…
Yissum Presents A Virtual Cane For The Visually Impaired
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, presented today at the Israeli Presidential Conference, a virtual cane that will significantly improve the orientation and mobility of sigh…
$3 Million Award To Develop Gene, Stem Cell Therapies For Common Eye Complication Of Diabetes
Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that ca…
Regeneron Announces EYLEA™ (aflibercept Ophthalmic Solution) Receives Unanimous Recommendation For Approval For Treatment Of Wet AMD From FDA
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S…
ACT Announces First Patients Enrolled In Two Clinical Trials Using Embryonic Stem Cells To Treat Stargardt’s Disease
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular…